WHO prequalified the OraQuick HCV self-test to enhance hepatitis C diagnosis and treatment. Only 36% of 50 million cases are diagnosed, and 20% treated, according to Dr. Meg Doherty. The 2021 HCVST recommendation complements services, targeting under-tested populations. Unsafe injections and unscreened blood cause 3500 daily deaths, highlighting the need for better diagnosis efforts. WHO prequalified the OraQuick HCV self-test to enhance hepatitis C diagnosis and treatment. Only 36% of 50 million cases are diagnosed, and 20% treated, according to Dr. Meg Doherty. The 2021 HCVST recommendation complements services, targeting under-tested populations. Unsafe injections and unscreened blood cause 3500 daily deaths, highlighting the need for better diagnosis efforts. Health and Fitness, Health Tips, Exercises & Workout Tips, Diet & Wellness | Times of India Lifestyle
WHO prequalifies, OraQuick HCV, the first self-test for hepatitis C virus
